Navigation Links
Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Date:9/10/2007

lozyme's proprietary drug delivery technology based on rHuPH20, a recombinant form of the naturally occurring human enzyme approved by FDA for its ability to break down hyaluronic acid, the space- filling "gel"-like substance that is a major component of tissues throughout the body. When combined or co-formulated with certain injectable drugs, Enhanze Technology can facilitate the penetration and dispersion of these drugs by temporarily opening flow channels under the skin. Molecules as large as 200 nanometers may pass freely through the perforated extracellular matrix, which recovers its normal density within approximately 24 hours, leading to a drug delivery platform that does not permanently alter the architecture of the skin.

About Baxter's GAMMAGARD LIQUID(TM) 10%

GAMMAGARD LIQUID 10% (known as KIOVIG(TM) in Europe) is indicated for the treatment of primary immunodeficiency disorders associated with defects in immune system. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

Important Safety Information for the United States

GAMMAGARD LIQUID 10% is contraindicated in patients with known anaphylactic or severe hypersensitivity responses to Immune Globulin (Human). Patients with severe selective IgA deficiency (IgA < 0.05 g/L) may develop anti-IgA antibodies that can result in a severe anaphylactic reaction.

Immune Globulin Intravenous (Human) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. Patients predisposed to acute renal failure include patients with any degree of pre-existing renal insufficiency, diabetes mellitus, age greater than 65, volume depletion, sepsis, paraproteinemia, or patients receiving known nephrotoxic drugs. Especially in such patients, IGIV products should be administered at the minimum concentration available and th
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...ne 30, 2008) Researchers at The University of Tex...erging Infectious Diseases and The University of T...) have identified a cell type believed to play a r...ainst Francisella tularensis, a respiratory path...ularemia. The findings will be released this week ...
...8 Signalife, Inc. (Amex:,SGN) announced that it h...hange ("AMEX") of its intent to voluntarily withdr...EX under AMEX Rule 18 and Section 1010 of the,AMEX...Signalife,s common,stock has been or will be short...s traded prior to listing with AMEX, and the compa...
...hirdBiotech Inc.,( http://www.thirdbiotech.com ), ...ation, today announced that Kemeta, a medical devi...ufacture of breath acetone sensing,technology and ...., (Logo: http://www.newscom.com/cgi-bin/prnh/20...shed ThirdBiotech as an organization for,bringing ...
Other Biology Technology:UTSA/UTHSCSA publish results on bio-threat agent 2Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB 2Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB 3Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB 4ThirdBiotech Announces Kemeta as Newest Sponsor 2
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3New evidence that dark chocolate helps ease emotional stress 10691 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 2Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 3NOVAVAX to Present at the Influenza Congress USA 2009 61142 1NOVAVAX to Present at the Influenza Congress USA 2009 61142 2
...ls reduce greenhouse-gas emissions in comparison t... Science, Smithsonian researchers highlight a new ...el production. Corn, soy and sugarcane come up sho...lective about which biofuels they support, as not ...fuels., Because fossil fuels contribute to global ...
...imple changes in its outer envelope protein could ...immune system, according to research from Kenya an...shed in PLoS Medicine. , The results could provid...vaccine, which is badly needed to decrease the num...2.5 million per year worldwide. , Although most p...
...N-SALEM, N.C. Hydrogen peroxide, the same mild ac...hens or treat cuts and abrasions, is also produced...rs at Wake Forest University School of Medicine ha... , Reporting in the January 3 issue of Nature, a ...ree-dimensional snapshot of how two proteins produ...
Other Biology News:Research explores role of hydrogen peroxide in cell health 2
Goat Anti-HSPC150 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2 from ABR-Affinity BioReagents
Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam
Mouse Anti-Aequorin Monoclonal Antibody, Unconjugated, Clone 2Q2147 from Abcam
Biology Products: